The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology

Pharmacology & Therapeutics
J J SandfordD J Nutt

Abstract

The authors provide an overview of the current state of knowledge with regards to the neurobiological mechanisms involved in normal and pathological anxiety. A brief review of the classification and cognitive psychology of anxiety is followed by a more in-depth look at the neuroanatomical and neurochemical processes and their relevance to our understanding of the modes of action of anxiolytic drugs. The serotonergic, noradrenergic, and gamma-aminobutyric acidergic systems are reviewed. The numerous physiological and pharmacological methods of anxiety provocation and the increasing importance of functional neuroimaging are also examined. The review provides an overview of the biology and basic pharmacology of anxiolytic drugs, and compliments the more clinically oriented companion review.

References

Sep 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·C Braestrup, R F Squires
Oct 20, 1992·European Journal of Pharmacology·H C Jackson, D J Nutt
Feb 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·D Nutt, C Lawson
Jan 1, 1992·Annual Review of Neuroscience·M Davis
May 1, 1992·Science·J J Kim, M S Fanselow
Jul 1, 1990·Acta Psychiatrica Scandinavica·D T GeorgeM Linnoila
Jun 15, 1991·Biological Psychiatry·J C WuJ C Johnson
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·D J NuttC Lawson
May 26, 1990·Lancet·J M RitterN Benjamin
Jan 1, 1990·Pharmacology & Therapeutics·D J Nutt
Nov 1, 1990·Biological Psychiatry·J M GormanF Jordan
Aug 1, 1990·Journal of Affective Disorders·H C Middleton
Feb 1, 1990·Acta Psychiatrica Scandinavica·D T GeorgeM Linnoila
Feb 1, 1990·Biological Psychiatry·R FontaineR Elie
Dec 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·G Hibbert, D Pilsbury
Feb 1, 1989·Archives of General Psychiatry·D J Nutt
Jul 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·D ZuckerW S Agras
May 1, 1989·Psychological Medicine·M G Gelder
Jan 1, 1989·Behaviour Research and Therapy·R Ley
Jun 1, 1989·Archives of General Psychiatry·E M ReimanK A Hackman
Jan 1, 1988·Archives of General Psychiatry·J M GormanD F Klein
Jan 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·A ClowM Sandler
Jan 1, 1985·Journal of Neurochemistry·J F Rehfeld
Jul 1, 1985·The American Journal of Psychiatry·A BreierG R Heninger
Oct 1, 1985·Pharmacology, Biochemistry, and Behavior·D P TaylorC P Vandermaelen
Nov 1, 1985·Journal of Affective Disorders·F K JuddT R Norman
Jul 1, 1986·The American Journal of Psychiatry·R M NesseM Lee
Nov 1, 1987·Medical Toxicology and Adverse Drug Experience·R AmreinG Roncari
Feb 1, 1989·Archives of General Psychiatry·T A Mellman, T W Uhde
May 1, 1987·Psychiatry Research·A P LevinS M Paul

❮ Previous
Next ❯

Citations

Oct 29, 2010·Psychopharmacology·Emily Freeman-DanielsLynn G Kirby
Jun 2, 2005·Pharmacology, Biochemistry, and Behavior·M P ViverosSandra E File
Dec 9, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Zul MeraliHymie Anisman
Apr 15, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Daniel J Lodge, Andrew J Lawrence
Nov 23, 2012·BMC Complementary and Alternative Medicine·Jie-Shu YouJian-You Guo
Feb 10, 2012·Interdisciplinary Toxicology·Natália SedláčkováMojmír Mach
Dec 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Xiaotang FanJan-Ake Gustafsson
May 16, 2007·Neural Plasticity·Allan V Kalueff
Jun 15, 2012·The International Journal of Neuropsychopharmacology·Alessandra TamburellaSalvatore Salomone
Aug 22, 2006·Behavioural Brain Research·A EnnaceurP L Chazot
Dec 21, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Emma L BurrowsAnthony J Hannan
Oct 16, 2016·Development and Psychopathology·Neil McNaughton, Philip J Corr
Sep 22, 2001·Journal of Psychopharmacology·J J SandfordD J Nutt
May 28, 2011·Journal of Psychopharmacology·F A MoreiraF S Guimarães
Jun 27, 2007·Journal of Psychopharmacology·Christian Gilles, Remy Luthringer
Oct 1, 2004·The Journal of Nervous and Mental Disease·James K BoehnleinBethany Rosborough
Nov 23, 2006·Depression and Anxiety·Allan V Kalueff, David J Nutt
Aug 31, 2010·Behavioural Pharmacology·Carla PisuLuca Pani
Jun 19, 2013·Asian Pacific Journal of Tropical Medicine·S N Harsha, K R Anilakumar
Apr 11, 2003·Neurogenetics·Deborah A FinnJohn C Crabbe
Aug 8, 2018·Pharmacological Reports : PR·Roman Tashev, Margarita Ivanova
Jul 30, 2019·Psychiatry Investigation·Woo-Young JungEun Young Jang
Sep 1, 2018·Pharmacological Reports : PR·Roman Tashev, Margarita Ivanova
Oct 7, 2004·European Journal of Pharmacology·Anthony S BasilePhil Skolnick
May 6, 2009·Pharmacology, Biochemistry, and Behavior·Priscila CagniMarilia Barros

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.